China-based WestGene's mRNA therapeutic cancer vaccine receives US FDA approval
Singapore, May 10 -- WestGene, a China-based biotech company dedicated to mRNA technology, has announced a historic milestone with the US FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an Epstein-Barr (EB) virus-related mRNA therapeutic cancer vaccine.
The US FDA approval of WGc-043 represents a significant advance in cancer treatment, offering new hope to patients with advanced EB virus-related cancers.
EB virus is highly correlated with more than ten malignancies, including nasopharyngeal carcinoma (NPC), natural killer T-cell lymphoma (NKTL), gastric cancer, lung cancer, liver cancer, esophageal cancer, breast cancer, cervical cancer, and autoimmune dise...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.